Platelet Aggregation Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Platelet Aggregation Devices Market: By Product (Systems, Reagents, Consumables, and Accessories), By Application (Clinical Applications, Research Applications), By End-user (Hospitals, Diagnostic Laboratories, Other End Users) and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Platelet Aggregation Devices market is estimated to be valued at USD 479.6 Million in 2021 and is poised to grow at a significant CAGR of 8.5% over 2022-2028. The platelet aggregation test contains venepuncture in a non-clotting medium made by centrifugation for separating the plasma. In this procedure, aggregometry is also used. The platelet aggregation procedure includes various medical devices that offer precise control over the active blood flow and thus monitor the formation of a platelet thrombus. Platelet aggregation devices contain devices such as platelet function analyser (PFA), aggregometer, platelet collection systems, and platelet function centrifuge. Based on the product, the platelet aggregation devices market is segmented into systems, reagents, consumables, and accessories. The Systems segment is anticipated to grow at a significant CAGR over the forecast years owing to the increasing automation of platelet aggregation testing procedures and growing adoption and market preference for automated instruments among diagnostic laboratories. The increasing problem of bleeding conditions is projected to raise the demand for platelet aggregation systems, as these are used to diagnose bleeding conditions. As per the data provided by Genetic Home Reference updates from July 2022, immune thrombocytopenia was projected at 4 per 100,000 in children and 3 per 100,000 in adults around the globe in 2020. The rising prevalence of chronic diseases, the growing elderly population, and technical improvements in platelet aggregation devices are the main drivers of the market.

 

Recent Market Developments:

In May 2022, the manufacturer of hemostasis diagnostic tools, Precision Biologic Inc., announced the introduction of their new cry check Chromogenic Factor IX test in Canada, European Union, the United Kingdom, Australia, and New Zealand.

Platelet Aggregation Devices Market

MARKET SUMMARY
-
8.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.5%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Platelet Aggregation Devices Market

  • The report on global platelet aggregation devices market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, application, end user and geography.
  • The global platelet aggregation devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • Hoffmann-La Roche Ltd
  • Haemonetics Corporation
  • Siemens Healthcare GmbH
Platelet Aggregation Devices Market Dynamics

The rise in target disease instances and the global expansion of the elderly population are two critical factors anticipated to propel the platelet aggregation devices market growth during the forecast period. It is also projected that increasing technical advancements in platelet aggregometer would fuel market expansion. Additionally, it is predicted that an increase in industry-academia partnerships and clinical investigations will temper the market expansion for platelet aggregation devices. On the other hand, it is anticipated that the platelet aggregation device market will be slow due to technological restrictions, inappropriate healthcare advancements, and a lack of experts with the necessary training, expertise, and skills.


North-America Got Significant Share

Platelet Aggregation Devices Market

The Platelet Aggregation Devices market in North America is likely to hold the highest revenue share in 2021. The same trend is expected over the forecast period due to the presence of device manufacturers, the rise of target disorders, the aging of the population, technical developments in platelet aggregation meters, and the growing understanding of the advantages of platelet aggregation testing among medical professionals. Additionally, the nation's expanding R&D expenditures might boost market expansion. Moreover, according to estimates revised in 2021 by the US Centers for Disease Control (CDC), an American may get a heart attack every 40 seconds. As a result, there will be an increase in demand for platelet aggregation devices, which will boost the market in the US.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The platelet aggregation devices market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Platelet Aggregation Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The platelet aggregation devices market is projected to expand at a CAGR of 8.5% during the forecast period

 

 

 

 

AggreDyne, Inc., Bio/Data Corporation, Chrono-Log Corporation, Hoffmann-La Roche Ltd, Haemonetics Corporation, Siemens Healthcare GmbH

North America  is the fastest-growing region for platelet aggregation devices market


Report

Company Profile

  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • Hoffmann-La Roche Ltd
  • Haemonetics Corporation
  • Siemens Healthcare GmbH
  • Werfen
  • Sysmex Corporation
  • Sienco, Inc.
  • Drucker Diagnostics
  • Heamochrom Diagnostica GmbH
  • Grifols, S.A.

Description

Platelet Aggregation Devices market is estimated to be valued at USD 479.6 Million in 2021 and is poised to grow at a significant CAGR of 8.5% over 2022-2028. The platelet aggregation test contains venepuncture in a non-clotting medium made by centrifugation for separating the plasma. In this procedure, aggregometry is also used. The platelet aggregation procedure includes various medical devices that offer precise control over the active blood flow and thus monitor the formation of a platelet thrombus. Platelet aggregation devices contain devices such as platelet function analyser (PFA), aggregometer, platelet collection systems, and platelet function centrifuge. Based on the product, the platelet aggregation devices market is segmented into systems, reagents, consumables, and accessories. The Systems segment is anticipated to grow at a significant CAGR over the forecast years owing to the increasing automation of platelet aggregation testing procedures and growing adoption and market preference for automated instruments among diagnostic laboratories. The increasing problem of bleeding conditions is projected to raise the demand for platelet aggregation systems, as these are used to diagnose bleeding conditions. As per the data provided by Genetic Home Reference updates from July 2022, immune thrombocytopenia was projected at 4 per 100,000 in children and 3 per 100,000 in adults around the globe in 2020. The rising prevalence of chronic diseases, the growing elderly population, and technical improvements in platelet aggregation devices are the main drivers of the market.

 

Recent Market Developments:

In May 2022, the manufacturer of hemostasis diagnostic tools, Precision Biologic Inc., announced the introduction of their new cry check Chromogenic Factor IX test in Canada, European Union, the United Kingdom, Australia, and New Zealand.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX